AneuRx Resolves U.S. Field Action, Is Featured In Separate U.K. Device Alert
This article was originally published in The Gray Sheet
Executive Summary
The U.K. Medical Device Agency's most recent medical device alert on Medtronic's AneuRx underscores the importance of anatomical features in deciding whether to treat a patient with the stent graft.
You may also be interested in...
FDA Notice Updates Medtronic AneuRx AAA-Related Death Statistics
Physician or institutional experience should be considered in determining whether to treat a AAA with a Medtronic AneuRx endovascular stent or open surgery, according to a 1Dec. 17 FDA public health notice
FDA Notice Updates Medtronic AneuRx AAA-Related Death Statistics
Physician or institutional experience should be considered in determining whether to treat a AAA with a Medtronic AneuRx endovascular stent or open surgery, according to a 1Dec. 17 FDA public health notice
UK Medical Devices Agency Issues AAA, Breast Implant Device Updates
Endovascualar prosthesis treatment outcomes remain contingent on factors such as aneurysmal remodeling and patients' vascular anatomy, the UK's Medical Devices Agency concludes in a 1May update on devices for abdominal and thoracic aortic aneurysms